Tag: AbbVie

AbbVie’s Crohn’s Disease Drug to Treat Patients in UK
April 20, 2022 Off

AbbVie’s Crohn’s Disease Drug to Treat Patients in UK

By Author

The UK Medicines and Healthcare Products Regulatory Agency (MHRA) has granted a positive scientific opinion under the Early Access to Medicines Scheme (EAMS) for AbbVie’s risankizumab for treatment of adults and adolescents (16-17 years) with Crohn’s Disease (CD) who have had an inadequate response to, lost response to or were intolerant or contraindicated to tumour necrosis factor-alpha (TNFα) antagonist therapies, vedolizumab and ustekinumab.

AbbVie and We Are Pioneer Group Launch Golden Ticket Programme to Help UK Life Science Start-ups Accelerate the Delivery of Life-Changing Innovations to Patients
April 4, 2022 Off

AbbVie and We Are Pioneer Group Launch Golden Ticket Programme to Help UK Life Science Start-ups Accelerate the Delivery of Life-Changing Innovations to Patients

By Dino Mustafić

AbbVie, the global research-driven biopharmaceutical company and We Are Pioneer Group (WAPG), Europe’s largest ecosystem provider for science and innovation businesses, to support the thriving UK life sciences start-up community, has launched a programme designed to help early-stage life science companies commercialise drug discovery and gain access to crucial research space.

Abbvie buys Allergan for $63B
October 14, 2019 Off

Abbvie buys Allergan for $63B

By Dino Mustafić

Allergan’s shareholders have voted to approve to be bought by AbbVie Inc for approximately $63 billion, as more than 99 percent of the votes cast were in favor of the transaction, representing about 69% of the shares outstanding and eligible to be voted at each of the Allergan shareholder meetings held on October 14, 2019 in Dublin, Ireland.